SE0023313762
SE0023313762
Apotea AB
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 8.85B EUR | 7.72B EUR | 6.56B EUR |
Enterprise Value | 9.04B EUR | 7.9B EUR | 6.75B EUR |
Valuation Multiples | |||
Trailing P/E | 36.02x | 31.12x | 27.55x |
Forward P/E | -- | -- | -- |
Price to Sales | 1.17x | 1.01x | 0.89x |
Price to Book | 9.34x | 8.15x | 7.1x |
EV/Revenue | 1.19x | 1.03x | 0.92x |
EV/EBITDA | 19.99x | 15.11x | 13.67x |
Price to FCF (P/FCF) | 89.25x | 30.25x | 34.94x |
EV/FCF | 91.19x | 30.94x | 35.95x |
FCF Yield | 1.12% | 3.31% | 2.86% |